Metformin has been the first-line drug treatment for hyperglycemia and insulin resistance for
over 50 years. However, the molecular basis of its therapeutic role remained incompletely …

Metformin has been a frontline therapy for type 2 diabetes (T2D) for many years. Its
effectiveness in T2D treatment is mostly attributed to its suppression of hepatic …

Metformin has been known for its antidiabetic effects for decades and is used as a first line
therapy in type 2 diabetes. But recently its anticancer potential has also been discovered …

Metformin is the first-line treatment for type 2 diabetes. Results from several clinical studies
have indicated that type 2 diabetic patients treated with metformin might have a lower cancer …

For decades, metformin has been the first-line drug for the treatment of type II diabetes
mellitus, and it thus is the most widely prescribed antihyperglycemic drug. Retrospective …

The deregulation of energetic and cellular metabolism is a signature of cancer cells. Thus,
drugs targeting cancer cell metabolism may have promising therapeutic potential. Previous …

Metformin is a biguanide widely prescribed to treat Type II diabetes that has gained interest
as an antineoplastic agent. Recent work suggests that metformin directly antagonizes …

Metformin has been a first-line treatment for type II diabetes mellitus for decades and is the
most widely prescribed antidiabetic drug. Retrospective studies have found that metformin …

Metformin, a first line medication for type II diabetes, initially entered the spotlight as a
promising anti-cancer agent due to epidemiologic reports that found reduced cancer risk …

Metformin, a biguanide derivative that is widely used for treating type 2 diabetes mellitus,
has recently been shown to exert potential anticancer effects. Many retrospective data and …